Iomeron (Iomeprol)

Iomeron, an iodinated contrast agent, is employed in imaging procedures that require enhanced X‑ray attenuation.

• Angiography: Provides detailed vascular visualization to aid diagnosis and interventional planning.
• Computed Tomography (CT) imaging: Improves soft‑tissue contrast for clearer cross‑sectional images.
• Myelography: Enhances spinal canal imaging for accurate assessment of nerve root and disc pathology.
• Other diagnostic imaging procedures requiring contrast: Facilitates visualization of organs and lesions where native tissue contrast is insufficient.

• Iomeron contains iomeprol, a low‑osmolar, non‑ionic iodinated compound that absorbs X‑rays more strongly than surrounding tissues. After intravenous, intra‑arterial, or intrathecal administration, the iodine atoms increase the attenuation of X‑ray beams, creating a temporary contrast between vascular or tissue structures and adjacent background, thereby improving image definition during radiographic examinations.

Iomeron may cause a range of adverse reactions following administration.

Common Side Effects

• Warmth or flushing sensation at the injection site.
• Metallic taste in the mouth.
• Nausea or mild vomiting.
• Transient headache.
• Mild urticaria or skin itching.
• Temporary increase in blood pressure.

Serious or Rare Side Effects

• Severe allergic reaction or anaphylaxis.
• Contrast‑induced nephropathy leading to acute kidney injury.
• Hypotension or cardiovascular collapse.
• Arrhythmias or cardiac arrest.
• Seizures or neurological disturbances.
• Persistent skin rash or Stevens‑Johnson syndrome.

Before using Iomeron, clinicians should consider several safety measures.

• Renal function assessment: evaluate baseline kidney function and consider hydration to reduce nephrotoxicity risk.
• Allergy history: screen for prior reactions to iodinated contrast agents or iodine‑containing substances.
• Thyroid disease: use caution in patients with hyperthyroidism or thyroid dysfunction.
• Medication review: assess concurrent use of nephrotoxic drugs and adjust therapy as needed.
• Pregnancy and lactation: weigh potential benefits against risks; use only when essential.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other agents that affect renal function or iodine metabolism.

Major Interactions (Avoid)

• Concurrent use of other high‑osmolar contrast agents: may increase risk of renal toxicity.
• Iodine‑containing medications (e.g., amiodarone) in patients with thyroid disease: can exacerbate thyroid dysfunction.
• Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs) combined with Iomeron may heighten renal injury risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask contrast‑induced tachycardia.
• Diuretics: may alter fluid balance and affect renal clearance.
• Metformin: consider temporary discontinuation in patients with impaired renal function to avoid lactic acidosis.